We are live on ! Find out more
TSVT

2seventy bio
TSVT

Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings

141 hedge funds and large institutions have $317M invested in 2seventy bio in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 40 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $500K | Put options by funds: $202K

58% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 19

25% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 32

6% more funds holding

Funds holding: 133 → 141 (+8)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

34% less capital invested

Capital invested by funds: $478M → $317M (-$161M)

Holders
141
Holders Change
+8
Holders Change %
+6.02%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
40
Reduced
32
Closed
19
Calls
$500K
Puts
$202K
Net Calls
+$298K
Net Calls Change
-$1.41M

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$17.4M
2
ECM
ExodusPoint Capital Management
New York
+$9.34M
3
Millennium Management
Millennium Management
New York
+$8.45M
4
BlackRock
BlackRock
New York
+$5.99M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.27M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$18.4M
2
RI
RTW Investments
New York
-$17.9M
3
EC
EcoR1 Capital
California
-$16.9M
4
SC
Sessa Capital
New York
-$4.45M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
126
Truvestments Capital
Florida
$384 -$28 -2 -5%
BWAM
127
Boyd Watterson Asset Management
Ohio
$384 +$578 +41 New
BCWM
128
Bartlett & Co Wealth Management
Ohio
$309 – – –
PFBT
129
Parkside Financial Bank & Trust
Missouri
$309 – – –
FFA
130
Fairfield Financial Advisors
Massachusetts
$187 – – –
GRP
131
Global Retirement Partners
California
$141 – – –
LFG
132
Larson Financial Group
Missouri
$75 – – –
TFM
133
TFC Financial Management
Massachusetts
$37 – – –
PA
134
Parallel Advisors
California
$28 – – –
FGAM
135
Financial Gravity Asset Management
Texas
$13 +$127 +9 New
LSA
136
Leonteq Securities AG
Switzerland
$9 – – –
NA
137
NewEdge Advisors
Louisiana
$2 +$2.62K +186 New
AC
138
Armistice Capital
New York
– -$18.4M -1,264,000 Closed
RI
139
RTW Investments
New York
– -$17.9M -1,229,508 Closed
SC
140
Sessa Capital
New York
– -$4.45M -305,633 Closed
Balyasny Asset Management
141
Balyasny Asset Management
Illinois
– -$4.1M -282,058 Closed
CCM
142
CAAS Capital Management
New York
– -$3.32M -228,245 Closed
ACM
143
Altium Capital Management
New York
– -$2.04M -140,000 Closed
MIM
144
Monashee Investment Management
Massachusetts
– -$1.02M -70,000 Closed
BNP Paribas Financial Markets
145
BNP Paribas Financial Markets
France
– -$776K -53,357 Closed
NFGH
146
Nan Fung Group Holdings
Hong Kong
– -$586K -40,273 Closed
D.E. Shaw & Co
147
D.E. Shaw & Co
New York
– -$245K -16,866 Closed
Ensign Peak Advisors
148
Ensign Peak Advisors
Utah
– -$169K -11,633 Closed
PM
149
Parametrica Management
Hong Kong
– -$161K -11,066 Closed
PHK
150
Point72 Hong Kong
Hong Kong
– -$54K -3,688 Closed
3 4 5
6
7

TSVT Hedge Fund Activity: Q4 2022 in Review

141 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2022, worth a combined $317M — down 34% from $478M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new TSVT positions and 19 closed out — a net gain of 11 holders — while 40 added to existing stakes and 32 trimmed.

The largest buyer was Casdin Capital, adding an estimated $17.4M. The largest seller was Armistice Capital, exiting entirely with an estimated $18.4M sold.

  • 141 institutional investors held 2seventy bio (TSVT) as of Q4 2022, up from 133 in Q3 2022.
  • Funds reported $317M of 2seventy bio stock for Q4 2022, down 34% quarter-over-quarter.
  • 30 funds opened new 2seventy bio positions in Q4 2022 and 19 closed out, a net change of +11 holders.
  • The largest 2seventy bio buyer in Q4 2022 was Casdin Capital, an estimated $17.4M added.
  • The largest 2seventy bio seller in Q4 2022 was Armistice Capital, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2022.